Settlement: AbbVie to Pay $3M in Androgel MDL Settlement

Chicago, IL: AbbVie Inc, the maker of Androgel, will pay $3 million to settle a defective product personal injury lawsuit, brought by a man from Oregon who alleged that his use of the testosterone replacement therapy caused him to suffer a heart attack.The lawsuit is part of a multi-district litigation (MDL) against several makers of testosterone replacement therapies, including Eli Lilly & Co., Endo, Auxilium and GlaxoSmithKline.